We are live on ! Find out more
PCA

Pallas Capital Advisors Portfolio holdings

AUM $3.25B
1-Year Est. Return 40.07%
This Fund
S&P 500
This Quarter Est. Return
-5.03%
1 Year Est. Return
+40.07%
3 Year Est. Return
+71.82%
5 Year Est. Return
+73.39%
10 Year Est. Return
AUM
$2.41B
AUM Growth
+$71.8M
Cap. Flow
+$273M
Cap. Flow %
11.32%
Top 10 Hldgs %
34.21%
Holding
806
New
226
Increased
355
Reduced
151
Closed
44

Sector Composition

Rank Sector Weight
1 Healthcare 22.96%
2 Technology 13.05%
3 Financials 7.15%
4 Energy 6.12%
5 Consumer Discretionary 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
176
McKesson
MCK
$101B
$2.17M 0.09%
3,225
+1,500
+87% +$927K
VV icon
177
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
$2.15M 0.09%
8,352
+93
+1% +$25.2K
HUM icon
178
Humana
HUM
$46.2B
$2.14M 0.09%
+8,072
New +$2.18M
BOXX icon
179
Alpha Architect 1-3 Month Box ETF
BOXX
$13.5B
$2.13M 0.09%
+19,140
New +$2.12M
EXR icon
180
Extra Space Storage
EXR
$31.6B
$2.12M 0.09%
14,266
+6,889
+93% +$1.04M
DKNG icon
181
DraftKings
DKNG
$11.9B
$2.12M 0.09%
63,725
+36,400
+133% +$1.5M
HUN icon
182
Huntsman Corp
HUN
$1.77B
$2.11M 0.09%
133,352
+108,508
+437% +$1.84M
CVS icon
183
CVS Health
CVS
$122B
$2.09M 0.09%
30,877
+20,480
+197% +$1.23M
GRMN
184
Garmin
GRMN
$60B
$2.07M 0.09%
9,516
+6,443
+210% +$1.39M
CUBE icon
185
CubeSmart
CUBE
$9.41B
$2.06M 0.09%
48,329
+9,222
+24% +$385K
MAR icon
186
Marriott International
MAR
$92.3B
$2.05M 0.09%
8,612
-4,643
-35% -$1.26M
SLV icon
187
iShares Silver Trust
SLV
$30.9B
$1.97M 0.08%
63,450
XEL icon
188
Xcel Energy
XEL
$48.8B
$1.96M 0.08%
27,620
-489
-2% -$33.3K
NTNX icon
189
Nutanix
NTNX
$16.9B
$1.89M 0.08%
27,134
+13,702
+102% +$948K
PCG icon
190
PG&E
PCG
$38.5B
$1.88M 0.08%
109,633
+91,553
+506% +$1.52M
VAC icon
191
Marriott Vacations Worldwide
VAC
$4.25B
$1.88M 0.08%
29,261
-2,232
-7% -$177K
EFA icon
192
iShares MSCI EAFE ETF
EFA
$80.2B
$1.88M 0.08%
22,975
-2,532
-10% -$204K
MDT icon
193
Medtronic
MDT
$112B
$1.86M 0.08%
20,653
+10,696
+107% +$957K
RL icon
194
Ralph Lauren
RL
$23.6B
$1.84M 0.08%
8,330
+4,545
+120% +$1.13M
BIIB icon
195
Biogen
BIIB
$30.7B
$1.83M 0.08%
13,345
+7,694
+136% +$1.1M
BMRN icon
196
BioMarin Pharmaceuticals
BMRN
$12.4B
$1.82M 0.08%
25,733
+22,527
+703% +$1.52M
EIX icon
197
Edison International
EIX
$26.4B
$1.82M 0.08%
+30,828
New +$1.77M
ALNY icon
198
Alnylam Pharmaceuticals
ALNY
$29.3B
$1.79M 0.07%
6,635
+3,227
+95% +$829K
XLRE icon
199
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.65B
$1.79M 0.07%
42,754
-3,765
-8% -$157K
EXEL icon
200
Exelixis
EXEL
$13.4B
$1.76M 0.07%
47,649
+25,322
+113% +$902K

Similar funds

Pallas Capital Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Pallas Capital Advisors held 806 positions worth $2.41B, up 3.1% from $2.34B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pallas Capital Advisors deployed $273M of net new capital in Q1 2025, opening 226 new positions and adding to 355 existing holdings. Its largest new stake was BlackRock Flexible Income ETF: 369,803 shares worth $19.4M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $30.7M trimmed.

  • Pallas Capital Advisors's largest Q1 2025 buy was BlackRock Flexible Income ETF: 369,803 shares worth $19.4M.
  • Pallas Capital Advisors added most to Janus Henderson Mortgage-Backed Securities ETF in Q1 2025, an estimated $40.2M increase.
  • Pallas Capital Advisors's biggest Q1 2025 reduction was Vanguard Total Bond Market, cutting an estimated $30.7M.
  • Pallas Capital Advisors fully exited iShares US Pharmaceuticals ETF in Q1 2025, selling an estimated $3.83M.
  • Pallas Capital Advisors's ten largest holdings make up 34% of its $2.41B portfolio in Q1 2025.
  • Pallas Capital Advisors opened 226 new positions and closed 44 in Q1 2025.
  • Pallas Capital Advisors's portfolio value rose 3.1% quarter-over-quarter to $2.41B.

Based on Pallas Capital Advisors's 13F filing for Q1 2025, filed 14 Apr 2025.